If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.
A monoclonal antibody with potential antineoplastic activity. Iratumumab is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin’s disease and other lymphomas, and other cancers. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
